Neuroendocrine differentiation in breast cancer: Established facts and unresolved problems

Seminars in Diagnostic Pathology

Volumn 27, Issue 1, 2010, Pages 69-76

  Righi, Luisella ^a   Sapino, Anna ^a   Marchiò, Caterina ^a   Papotti, Mauro ^a   Bussolati, Gianni ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Breast cancer; Chromogranin; Histologic special type; Neuroendocrine; Synaptofisin

Indexed keywords

CHROMOGRANIN A; EPIDERMAL GROWTH FACTOR RECEPTOR 2; SYNAPTOPHYSIN;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER MORPHOLOGY; CARCINOGENESIS; CARCINOMA; CYTOLOGY; DISEASE MARKER; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LUNG ALVEOLUS CELL CARCINOMA; MUCINOUS CARCINOMA; NEUROENDOCRINE BREAST CANCER; NEUROENDOCRINE TUMOR; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMALL CELL CARCINOMA; SOLID COHESIVE CARCINOMA; SOLID TUMOR; TISSUE DIFFERENTIATION;

ADENOCARCINOMA, MUCINOUS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, NEUROENDOCRINE; CELL TRANSFORMATION, NEOPLASTIC; CHROMOGRANIN A; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 77349088521     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2009.12.003     Document Type: Article

References (57)

1. Cubilla A.L., Woodruff J.M. Primary carcinoid tumor of the breast. A report of eight patients. Am J Surg Pathol 1977, 1:283-292.
2. Cross A.S., Azzopardi J.G., Krausz T., et al. A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathology 1985, 9:21-37.
3. Sapino A., Righi L., Cassoni P., et al. Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 2000, 17:127-137.
4. Bussolati G., Gugliotta P., Sapino A., et al. Chromogranin-reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast. Am J Pathol 1985, 120:186-192.
5. Pagani A., Papotti M., Hofler H., et al. Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses. Am J Pathol 1990, 136:319-327.
6. Ellis P., Schnitt S.J., Sastre-Garau X. Invasive breast carcinoma. Tumours of the Breast and Female Genital Organs: Pathology and Genetics 2003, IARC Press, Lyon, France. F.A. Tavassoli, P. Devilee (Eds.).
7. Maluf H.M., Koerner F.C. Carcinomas of the breast with endocrine differentiation: A review. Virchows Arch 1994, 425:449-457.
8. Hull M.T., Warfel K.A. Mucinous breast carcinomas with abundant intracytoplasmic mucin and neuroendocrine features: Light microscopic, immunohistochemical, and ultrastructural study. Ultrastruct Pathol 1987, 11:29-38.
9. Papotti M., Tanda F., Bussolati G., et al. Argyrophilic neuroendocrine carcinoma of the male breast. Ultrastruct Pathol 1993, 17:115-121.
10. Taxy J.B., Tischler A.S., Insalaco S.J., et al. "Carcinoid" tumor of the breast. A variant of conventional breast cancer?. Hum Pathol 1981, 12:170-179.
11. Fisher E.R., Palekar A.S. Solid and mucinous varieties of so-called mammary carcinoid tumors. Am J Clin Pathol 1979, 72:909-916.
12. Papotti M., Macri L., Finzi G., et al. Neuroendocrine differentiation in carcinomas of the breast: A study of 51 cases. Semin Diagn Pathol 1989, 6:174-188.
13. Capella C., Eusebi V., Mann B., et al. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 1980, 4:613-630.
14. Lopez-Bonet E., Alonso-Ruano M., Barraza G., et al. Solid neuroendocrine breast carcinomas: Incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep 2008, 20:1369-1374.
15. Volante M., Righi L., Asioli S., et al. Goblet cell carcinoids and other mixed neuroendocrine/nonneuroendocrine neoplasms. Virchows Arch 2007, 451(suppl 1):S61-S69.
16. Sapino A., Righi L., Cassoni P., et al. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol 2001, 14:768-776.
17. Papotti M., Gherardi G., Eusebi V., et al. Primary oat cell (neuroendocrine) carcinoma of the breast. Report of four cases. Virchows Arch A Pathol Anat Histopathol 1992, 420:103-108.
18. Adegbola T., Connolly C.E., Mortimer G. Small cell neuroendocrine carcinoma of the breast: A report of three cases and review of the literature. J Clin Pathol 2005, 58:775-778.
19. Ersahin C., Bandyopadhyay S., Bhargava R. Thyroid transcription factor-1 and "basal marker"-Expressing small cell carcinoma of the breast. Int J Surg Pathol 2009, 17:368-372.
20. Shin S.J., DeLellis R.A., Rosen P.P. Small cell carcinoma of the breast-Additional immunohistochemical studies. Am J Surg Pathol 2001, 25:831-832.
21. Moriya T., Kanomata N., Kozuka Y., et al. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions. Breast Cancer 2009, 16:173-178.
22. Capella C., Usellini L., Papotti M., et al. Ultrastructural features of neuroendocrine differentiated carcinomas of the breast. Ultrastruct Pathol 1990, 14:321-334.
23. Makretsov N., Gilks C.B., Coldman A.J., et al. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol 2003, 34:1001-1008.
24. Kiriakogiani-Psaropoulou P., Malamou-Mitsi V., Martinopoulou U., et al. The value of neuroendocrine markers in non-small cell lung cancer: A comparative immunohistopathologic study. Lung Cancer 1994, 11:353-364.
25. Papotti M., Sapino A., Righi L., et al. 34betaE12 cytokeratin immunodetection in the differential diagnosis of neuroendocrine carcinomas of the breast. Appl Immunohistochem Mol Morphol 2001, 9:229-233.
26. Tse G.M., Tan P.H., Lau K.M., et al. Breast cancer in the elderly: A histological assessment. Histopathology 2009, 55:441-451.
27. Haagensen D.E., Mazoujian G., Dilley W.G., et al. Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein. J Natl Cancer Inst 1979, 62:239-247.
28. Abrahamsson P.A. Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer 1999, 6:503-519.
29. Papotti M., Macri L., Bussolati G., et al. Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas. Int J Cancer 1989, 43:365-369.
30. Reubi J.C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003, 24:389-427.
31. Bootsma A.H., van Eijck C., Schouten K.K., et al. Somatostatin receptor-positive primary breast tumors: Genetic, patient and tumor characteristics. Int J Cancer 1993, 54:357-362.
32. Korner M., Eltschinger V., Waser B., et al. Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: Lessons from the comparison of anti-sst2A antibodies with somatostatin receptor autoradiography. Am J Surg Pathol 2005, 29:1642-1651.
33. Reubi J.C., Macke H.R., Krenning E.P. Candidates for peptide receptor radiotherapy today and in the future. J Nucl Med 2005, 46(suppl 1):67S-75S.
34. Panareo S., Carcoforo P., Lanzara S., et al. Radiolabelled somatostatin analogs for diagnosis and radio-guided surgery of neuroendocrine breast cancer undetectable with conventional imaging procedures. Breast 2008, 17:111-114.
35. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
36. Sorlie T., Tibshirani R., Parker J., et al. Repeated observation of breast tumor subtypes in independent gene expression datasets. Proc Natl Acad Sci U S A 2003, 100:8418-8423.
37. Hu Z., Fan C., Oh D.S., et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006, 7:96.
38. Weigelt B., Horlings H.M., Kreike B., et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 2008, 216:141-150.
39. Weigelt B., Geyer F.C., Horlings H.M., et al. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type. Mod Pathol 2009, 22:1401-1414.
40. Sapino A., Papotti M., Pietribiasi F., et al. Diagnostic cytological features of neuroendocrine differentiated carcinoma of the breast. Virchows Arch 1998, 433:217-222.
41. Tang W., Taniguchi E., Wang X., et al. Loss of cell cohesion in breast cytology as a characteristic of neuroendocrine carcinoma. Acta Cytol 2002, 46:835-840.
42. Ng W.K., Poon C.S., Kong J.H. Fine needle aspiration cytology of ductal breast carcinoma with neuroendocrine differentiation. Review of eight cases with histologic correlation. Acta Cytol 2002, 46:325-331.
43. Rovera F., Masciocchi P., Coglitore A., et al. Neuroendocrine carcinomas of the breast. Int J Surg 2008, 6(suppl 1):S113-S115.
44. Berruti A., Saini A., Leonardo E., et al. Management of neuroendocrine differentiated breast carcinoma. Breast 2004, 13:527-529.
45. Tse G.M., Ma T.K., Chu W.C., et al. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters. Mod Pathol 2004, 17:568-572.
46. Sapino A., Papotti M., Righi L., et al. Clinical significance of neuroendocrine carcinoma of the breast. Ann Oncol 2001, 12(suppl 2):S115-S117.
47. van Krimpen C., Elferink A., Broodman C.A., et al. The prognostic influence of neuroendocrine differentiation in breast cancer: Results of a long-term follow-up study. Breast 2004, 13:329-333.
48. Miremadi A., Pinder S.E., Lee A.H., et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 2002, 40:215-222.
49. Berruti A., Mosca A., Porpiglia F., et al. Chromogranin A expression in patients with hormone naive prostate cancer predicts the development of hormone refractory disease. J Urol 2007, 178:838-843.
50. Tsang W.Y., Chan J.K. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: A form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 1996, 20:921-943.
51. Satake T., Matsuyama M. Endocrine cells in a normal breast and non-cancerous breast lesion. Acta Pathol Jpn 1991, 41:874-878.
52. Fetissof F., Dubois M.P., Arbeille-Brassart B., et al. Argyrophilic cells in mammary carcinoma. Hum Pathol 1983, 14:127-134.
53. Kawasaki T., Nakamura S., Sakamoto G., et al. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast-Comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases. Histopathology 2008, 53:288-298.
54. Rindi G., Buffa R., Sessa F., et al. Chromogranin A, B and C immunoreactivities of mammalian endocrine cells. Distribution, distinction from costored hormones/prohormones and relationship with the argyrophil component of secretory granules. Histochemistry 1986, 85:19-28.
55. Rossi S., Laurino L., Furlanetto A., et al. Rabbit monoclonal antibodies: A comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. Am J Clin Pathol 2005, 124:295-302.
56. Iyoda A., Hiroshima K., Toyozaki T., et al. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer 2001, 91:1992-2000.
57. Giovanella L., Marelli M., Ceriani L., et al. Evaluation of chromogranin A expression in serum and tissues of breast cancer patients. Int J Biol Markers 2001, 16:268-272.